The Karnataka High Court has dismissed a plea by M/s Life Vision Healthcare and its managing partner Naveen Kumar Bansal seeking quashing of criminal proceedings over alleged manufacture and marketing of substandard tablets, with Justice Rajesh Rai K passing the order on November 2.
At issue were Impcal Tablets described as Calcium Orotate with Vitamin D3 Tablets IP bearing batch number LTA-2497 manufactured in September 2019, which chemical analysis declared Not of Standard Quality with reference to the vitamin ingredient.
According to the order, the authorities communicated the adverse test report on August 28, 2020. The request for re-analysis came on April 15, 2021, after the shelf life of the drug had expired in February 2021.
Investigators seized the sample on February 18, 2020 and forwarded it for chemical analysis on February 20, 2020.
Two-day gap not undue delay
The petitioners contended before the bench that the gap breached Section 23(4)(i) of the Drugs and Cosmetics Act, 1940 and had prejudiced the statutory right to seek re-analysis by the Central Drugs Laboratory.
On that argument, the bench held in the order that the expression ‘forthwith’ did not require forwarding without completing the other procedural steps prescribed under the statute.
“Forwarding the seized drug sample for chemical analysis within two days cannot, in the facts and circumstances of the present case, be construed as an undue or unexplained delay,” the order states.
Bansal pleaded before the bench that he could not face prosecution merely by virtue of designation.
The bench rejected that plea after finding that the complaint prima facie indicated active involvement in day-to-day affairs of the company.
“The allegations, if established, have a direct bearing on public health and cannot be lightly brushed aside at this stage,” the bench observed in the order.
A full-fledged trial is needed, the bench held. Advocates Nitin Bashir and Uday Urs appeared for the petitioners and Government Pleader Mahesha P appeared for the State, as recorded in the order.
LawWorld Pro
Research, drafting and case management for the whole practice.
₹1,500 per month, or ₹12,000 per year — save 33%. 1 user, 250 active cases, 10 GB. Prices exclusive of 18% GST.
Comments
Sign in to read the discussion and share your thoughts.
Latest from LawWorld
News
View all- Supreme Court Protects Birbhum Stone Quarry Accused From Coercive Action Till December 521 Nov 2026
- Supreme Court Orders Medical Examination Of 70-Year-Old Convict In 1981 Dumka Double Murder21 Nov 2026
- Supreme Court Caps Arbitral Award To Monetary Limit Of Referred Dispute21 Nov 2026
- Karnataka High Court Quashes Summoning Order Against Head Constable, Orders Fresh Process21 Nov 2026
- Karnataka High Court Upholds IGST Export Refund After Omission of Rule 96(10)21 Nov 2026








